Concepedia

Tumor Mutational Profiling

Tumor Mutational Profiling is a molecular diagnostic method that identifies and characterizes the spectrum of somatic genetic alterations within tumor-derived biomarkers in liquid biopsy samples to enable non-invasive cancer genotyping.

728

Publications

55.5K

Citations

7.6K

Authors

1.7K

Institutions

Publications per year

2017–2026

413

Parents

Publications

728

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

Robert Samstein, Chung‐Han Lee, Alexander N. Shoushtari et al. · Nature Genetics · 2019 · 4.4K citations · Full text

, , +14

Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)

Donavan T. Cheng, Talia Mitchell, Ahmet Zehir et al. · Journal of Molecular Diagnostics · 2015 · 2.2K citations · Full text

, , +14

Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma

Brett Johnson, Tali Mazor, Chibo Hong et al. · Science · 2013 · 1.4K citations

, , +17

Detection and quantification of mutations in the plasma of patients with colorectal tumors

Frank Diehl, Meng Li, Devin Dressman et al. · Proceedings of the National Academy of Sciences · 2005 · 1.2K citations · Full text

, , +12

Long-Term Results From a Randomized Phase II Trial of Standard- Versus Higher-Dose Imatinib Mesylate for Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing <i>KIT</i>

Charles D. Blanke, George D. Demetri, Margaret von Mehren et al. · Journal of Clinical Oncology · 2008 · 1K citations · Full text

, , +14

1–5 of 728

Authors

7.6K

  1. AJ
    A. John Iafrate

    Massachusetts General Hospital, United States

    11 publications · 2.5K citations

    11

    h-index

  2. ML
    Marc Ladanyi

    Memorial Sloan Kettering Cancer Center, United States

    9 publications · 7.3K citations

    9

    h-index

  3. RB
    Richard B. Lanman

    Guardant (United States), United States

    8 publications · 440 citations

    8

    h-index

  4. GR
    Geoffrey R. Oxnard

    Dana-Farber Cancer Institute, United States

    8 publications · 1.6K citations

    8

    h-index

  5. AS
    Aldo Scarpa

    University of Verona, Italy

    8 publications · 510 citations

    8

    h-index

1–5 of 7.6K

Institutions

1.7K

  1. The University of Texas MD Anderson Cancer Center

    Houston, United States

    28 h-index

    217 publications

    43.8K citations

  2. Memorial Sloan Kettering Cancer Center

    New York, United States

    28 h-index

    362 publications

    333.9K citations

  3. Dana-Farber Cancer Institute

    Boston, United States

    27 h-index

    191 publications

    52.7K citations

  4. Massachusetts General Hospital

    Boston, United States

    25 h-index

    271 publications

    48.6K citations

  5. Harvard University

    Cambridge, United States

    24 h-index

    213 publications

    43.7K citations

  6. Inserm

    Paris, France

    20 h-index

    139 publications

    19.8K citations

  7. Johns Hopkins University

    Baltimore, United States

    19 h-index

    130 publications

    32.3K citations

  8. Brigham and Women's Hospital

    Boston, United States

    19 h-index

    112 publications

    17.4K citations

1–8 of 1.7K

Venues

  1. Clinical Cancer Research

    32 publications · 3.8K citations

    29

    h-index

  2. PLoS ONE

    39 publications · 2.3K citations

    24

    h-index

  3. Oncotarget

    27 publications · 1.9K citations

    21

    h-index

  4. BMC Cancer

    18 publications · 718 citations

    15

    h-index

  5. Scientific Reports

    16 publications · 842 citations

    15

    h-index

1–5